Clovis Oncology Other Liabilities

Clovis Oncology (CLVS) currently reports a other liabilities of $0 as of September 2022. That compares with $630K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Clovis Oncology's other liabilities history and peer comparisons.

Clovis Oncology's other liabilities decreased from $630K to $0 — a 100.0% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clovis Oncology reported $0 in other liabilities as of September 2022. That compares with $630K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Clovis Oncology, and consider following CLVS for alerts when major investors trade the stock.

Clovis Oncology is classified in the Healthcare sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLVS with unrelated industries.